MedTrace Logo

Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).

NCT02602483 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2017-01-19

No results posted yet for this study

Summary

The objetive of this study is to explore the efficacy and safety of a triple combination of ibuprofen, magnesium and ascorbic acid for acute pain treatment in TMJD patients

Conditions

  • Temporomandibular Joint Disorders

Interventions

DRUG

Ibuprofen

DRUG

Magnesium

DRUG

Ascorbic Acid

DRUG

Placebo

Sponsors & Collaborators

  • Universitat Internacional de Catalunya

    collaborator OTHER

  • Hospital Odontològic UB

    collaborator OTHER

  • Hospital Universitario La Fe

    collaborator OTHER

  • Hospital Universitario Rey Juan Carlos

    collaborator OTHER

  • Spherium Biomed

    lead INDUSTRY

Principal Investigators

  • Giner Lluis, MD · Clinica Universitaria Odontologica de la Universidad Internacional de Cataluña

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602483 on ClinicalTrials.gov